Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rial-Sebbag E."'
Autor:
de Wert G; Department of Health, Ethics and Society, CAPHRI Care and Public Health Research Institute, and Research School GROW for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands. g.dewert@maastrichtuniversity.nl., Dondorp W; Department of Health, Ethics and Society, CAPHRI Care and Public Health Research Institute, and Research School GROW for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands., Clarke A; Institute of Medical Genetics, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK., Dequeker EMC; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium., Cordier C; Département de génétique, SYNLAB, Chemin d'Entre-Bois 21, 1018, Lausanne, Switzerland., Deans Z; UK National External Quality Assessment Service for Molecular Genetics/Genomics Quality Assessment, Department of Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK., van El CG; Section Community Genetics, Department of Clinical Genetics and Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Fellmann F; The ColLaboratory, University of Lausanne, Lausanne, Switzerland., Hastings R; CEQAS/GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Hentze S; Praxis für Humangenetik, Mannheim, Germany., Howard H; Medical Ethics, Lund Universitet, Lund, SE-221 00, Sweden.; Division of Industrial Biotechnology, Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 412 96, Sweden., Macek M; Department of Biology and Medical Genetics, Charles University and Motol University Hospital, Prague, Czech Republic., Mendes A; UnIGENe and CGPP-Centre for Predictive and Preventive Genetics, IBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Patch C; Genomics England, Queen Mary University of London, London, UK.; Society and Ethics Research Group, Connecting Science, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Rial-Sebbag E; Laboratoire d'Épidémiologie et de Santé Publique, UMR 1027 INSERM, Université Paul-Sabatier, Toulouse, France., Stefansdottir V; Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavik, Iceland., Cornel MC; The ColLaboratory, University of Lausanne, Lausanne, Switzerland., Forzano F; Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2021 Mar; Vol. 29 (3), pp. 365-377. Date of Electronic Publication: 2020 Nov 22.
Autor:
Carrieri D; University of Exeter, Egenis, UK., Howard HC; Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden., Benjamin C; School of Community Health & Midwifery, University of Central Lancashire (UCLan), Preston, England, UK.; Merseyside and Cheshire Clinical Genetics Service, Liverpool Women's NHS Hospital Trust, Liverpool, England, UK., Clarke AJ; School of Medicine, Cardiff University, United Kingdom 9 School of Medicine, University of Exeter, Egenis, UK., Dheensa S; Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK., Doheny S; School of Medicine, Cardiff University, United Kingdom 9 School of Medicine, University of Exeter, Egenis, UK., Hawkins N; Law School, University of Exeter, Exeter, UK., Halbersma-Konings TF; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Jackson L; School of Medicine, University of Exeter, Exeter, UK., Kayserili H; Medical Genetics Department, Koç University School of Medicine (KUSoM), İstanbul, Turkey., Kelly SE; University of Exeter, Egenis, UK., Lucassen AM; Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK.; Wessex Clinical Genetics Service, University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Mendes Á; UnIGENe and CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Molecular and Cell Biology, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Rial-Sebbag E; UMR 1027, Inserm, Université Paul Sabatier-Toulouse III, Toulouse, Cedex, France., Stefánsdóttir V; Landspitali - the National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavík, Iceland., Turnpenny PD; Clinical Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., van El CG; Section Community Genetics, Department of Clinical Genetics and Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands., van Langen IM; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Cornel MC; Section Community Genetics, Department of Clinical Genetics and Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands., Forzano F; Clinical Genetics Department, Guy's & St. Thomas' NHS Foundation Trust, London, UK. Francesca.Forzano@gstt.nhs.uk.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2019 Feb; Vol. 27 (2), pp. 169-182. Date of Electronic Publication: 2018 Oct 11.
Autor:
de Wert G; Department of Health, Ethics and Society, Research Institutes GROW and CAPHRI, Fac. of Health, Medicine and the Life Sciences, Maastricht University, Maastricht, The Netherlands. g.dewert@maastrichtuniversity.nl., Pennings G; Bioethics Institute Ghent, Department of Philosophy and Moral Science, Ghent University, Ghent, Belgium., Clarke A; School of Medicine, Cardiff University, Cardiff, UK., Eichenlaub-Ritter U; Institute of Gene Technology/Microbiology, Faculty of Biology, University of Bielefeld, Bielefeld, Germany., van El CG; Department of Clinical Genetics, Section Community Genetics, and Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands., Forzano F; Clinical Genetics Department, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK., Goddijn M; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam-Zuidoost, The Netherlands., Heindryckx B; Ghent-Fertility and Stem cell Team (G-FaST), Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium., Howard HC; Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden., Radojkovic D; Laboratory for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Rial-Sebbag E; University Paul Sabatier Toulouse, Toulouse, France., Tarlatzis BC; 1st Department of Obstetrics & Gynecology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Cornel MC; Department of Clinical Genetics, Section Community Genetics, and Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2018 Apr; Vol. 26 (4), pp. 445-449. Date of Electronic Publication: 2018 Jan 12.
Autor:
De Wert G; Department of Health, Ethics and Society, Research Institutes GROW and CAPHRI, Faculty of Health, Medicine and the Life Sciences, Maastricht University, Maastricht, The Netherlands. g.dewert@maastrichtuniversity.nl., Heindryckx B; Ghent-Fertility and Stem cell Team (G-FaST), Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium., Pennings G; Bioethics Institute Ghent, Department of Philosophy and Moral Science, Ghent University, Ghent, Belgium., Clarke A; School of Medicine, Cardiff University, Cardiff, UK., Eichenlaub-Ritter U; Institute of Gene Technology/Microbiology, Faculty of Biology, University of Bielefeld, Bielefeld, Germany., van El CG; Department of Clinical Genetics, Section Community Genetics and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands., Forzano F; Clinical Genetics Department, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK., Goddijn M; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam-Zuidoost, The Netherlands., Howard HC; Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden., Radojkovic D; Laboratory for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Rial-Sebbag E; University Paul Sabatier Toulouse, Toulouse, France., Dondorp W; Department of Health, Ethics and Society, Research Institutes GROW and CAPHRI, Faculty of Health, Medicine and the Life Sciences, Maastricht University, Maastricht, The Netherlands., Tarlatzis BC; 1st Department of Obstetrics & Gynecology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Cornel MC; Department of Clinical Genetics, Section Community Genetics and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2018 Apr; Vol. 26 (4), pp. 450-470. Date of Electronic Publication: 2018 Jan 12.
Autor:
Chabannon C; Centre de thérapie cellulaire, département de biologie du cancer, institut Paoli-Calmettes, 232 boulevard Sainte-Marguerite, 13273 Marseille Cedex, France - Aix-Marseille université (AMU), Marseille, France - Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France., Sabatier F; Aix-Marseille université (AMU), Marseille, France - Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France - laboratoire de culture et de thérapie cellulaire, hôpital de la Conception, Assistance publique-hôpitaux de Marseille, Marseille, France., Rial-Sebbag E; Inserm UMR 1027, épidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps, équipe génomique, biothérapies et santé publique-approche interdisciplinaire, Toulouse, France - université Paul Sabatier-Toulouse 3, Toulouse, France., Calmels B; Centre de thérapie cellulaire, département de biologie du cancer, institut Paoli-Calmettes, 232 boulevard Sainte-Marguerite, 13273 Marseille Cedex, France - Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France., Veran J; Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France - laboratoire de culture et de thérapie cellulaire, hôpital de la Conception, Assistance publique-hôpitaux de Marseille, Marseille, France., Magalon G; Aix-Marseille université (AMU), Marseille, France - Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France - laboratoire de culture et de thérapie cellulaire, hôpital de la Conception, Assistance publique-hôpitaux de Marseille, Marseille, France., Lemarie C; Centre de thérapie cellulaire, département de biologie du cancer, institut Paoli-Calmettes, 232 boulevard Sainte-Marguerite, 13273 Marseille Cedex, France - Inserm-centre d'investigations cliniques en biothérapie (CBT)-510, Marseille, France., Mahalatchimy A; Inserm UMR 1027, épidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps, équipe génomique, biothérapies et santé publique-approche interdisciplinaire, Toulouse, France - université Paul Sabatier-Toulouse 3, Toulouse, France - Institut de recherche en droit européen, international et comparé (IRDEIC), université Toulouse 1-Capitole, Toulouse, France.
Publikováno v:
Medecine sciences : M/S [Med Sci (Paris)] 2014 May; Vol. 30 (5), pp. 576-83. Date of Electronic Publication: 2014 Jun 13.